The following is a summary of “Association of mutation profiles with metastasis in patients with non-small cell lung cancer,” ...

The FDA is looking at four events for the remainder of October, one of which is an advisory committee meeting for a dual SGLT ...

Researchers are making progress toward vaccines that train healthy people’s immune systems to eliminate signs of cancer ...

Northwestern Medicine investigators have discovered that a novel combination therapy promotes cancer cell death and tumor ...

Despite higher levels of mRNA encoding SG proteins during pancreatic tumorigenesis, this study finds no SG formation in ...

BioAtla Inc (BCAB) reports promising clinical advancements and strategic partnerships despite financial hurdles in Q2 2024.

GRAND CAYMAN, CAYMAN ISLANDS / ACCESSWIRE / October 9, 2024 / Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion" or the "Company"), a clinical-stage biotech developing RNA interference (RNAi) ...

All cells within the same cancer are not the same. They all have genetic errors that turn them into tumour cells, but these errors are not identical.

A new tool detects the evolutionary advantages of multiple myeloma cells over the different treatments available. The information it provides can help prevent the tumor from becoming resistant to ...

All cells within the same cancer are not the same. They all have genetic errors that turn them into tumour cells, but these errors are not identical ...

Discover Cardiff Oncology's promising results with Onvansertib for RAS-mutated colorectal cancer, potentially leading to ...